In Brief Sylvester Comprehensive Cancer Center creates two endowed chairs February 12, 2016Vol.42 No.06
Drugs & Targets FDA grants orphan designation to antifungal drug candidate CD101 IV February 12, 2016Vol.42 No.06
In Brief David McConkey appointed director of Johns Hopkins Bladder Institute February 12, 2016Vol.42 No.06
Drugs & Targets Mayo Clinic collaborates with Morphotek in triple-negative breast cancer study. February 05, 2016Vol.42 No.05
Drugs & Targets FDA tells Telesta they need another phase III MCNA trial February 05, 2016Vol.42 No.05
Drugs & Targets Venetoclax Receives Third Breakthrough Designation from FDA February 05, 2016Vol.42 No.05
